India approves Entod Pharmaceuticals' PresVu eye drops for presbyopia treatment.

Entod Pharmaceuticals has received approval from India's Drug Controller General for PresVu eye drops, the first product aimed at treating presbyopia, a common age-related vision condition. Designed to reduce reliance on reading glasses, PresVu will be available in pharmacies starting in October for Rs 350, by prescription only. The company plans to market the drops domestically and in emerging markets, while also exploring future innovations in mental health.

September 03, 2024
25 Articles